FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Aurobindo Pharma Levetiracetam Tablets 750 mg 120-count Recall

Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobind…

Aurobindo Pharma USA Inc. · East Windsor, NJ

Risk level
Class II
Reported by FDA
Apr 22, 2020
Recall ID
D-1233-2020
Check your lot numberHow we source this data

Summary

Aurobindo Pharma recalled Levetiracetam Tablets 750 mg 120-count starting Mar 18, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1233-2020 on Apr 22, 2020. Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed. Status: Terminated.

Why it was recalled

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Product description

Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08

Lot numbers, UPCs & expiration codes

Lot #: 24719001A1, Exp. Date 03/2021

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1233-2020
Classification
Class II
Status
Terminated
Recall initiated
Mar 18, 2020
FDA report date
Apr 22, 2020
Quantity
8040 units
Recall type
Voluntary: Firm initiated
Recalling firm
Aurobindo Pharma USA Inc.

Original FDA data

Every field from FDA enforcement report D-1233-2020, exactly as published.

Show all FDA fields
City
East Windsor
State
NJ
Status
Terminated
Country
United States
Event ID
85183
Address
279 Princeton Hightstown Rd
Code information
Lot #: 24719001A1, Exp. Date 03/2021
Postal code
08520-1401
Report date
Apr 22, 2020
Product type
Drugs
Recall number
D-1233-2020
Classification
Class II
Recalling firm
Aurobindo Pharma USA Inc.
Product quantity
8040 units
Termination date
Mar 25, 2024
Reason for recall
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08
Distribution pattern
Nationwide within the United States
Recall initiation date
Mar 18, 2020
Initial firm notification
Letter
Center classification date
Apr 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1233-2020, published Apr 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls